Bristol Myers Squibb (CELG-RI) Dividends Paid - Common (2009 - 2026)
Bristol Myers Squibb (CELG-RI) posted quarterly Dividends Paid - Common of $1.3 billion for Q1 2026, up 1.99% YoY from $1.3 billion in Q1 2025, and up 1.66% sequentially from $1.3 billion in Q4 2025.
Bristol Myers Squibb (CELG-RI) Dividends Paid - Common (2009 - 2026) Analysis & Trends
Bristol Myers Squibb has disclosed Dividends Paid - Common across 18 years of filings, most recently posting $1.3 billion for Q1 2026.
- In Q1 2026, Dividends Paid - Common rose 1.99% year-over-year to $1.3 billion; the TTM figure through Mar 2026 stood at $5.1 billion (up 3.28% YoY), while the FY2025 annual figure was $5.0 billion, up 3.74% from the prior year.
- Dividends Paid - Common rose to $1.3 billion in Q1 2026, from $1.3 billion in the prior quarter.
- Over the last five years, Dividends Paid - Common for CELG-RI reached as high as $1.3 billion in Q1 2026 and fell as low as $12.0 million in Q2 2022.
- The 5-year median for Dividends Paid - Common is $1.2 billion (2024), against an average of $1.1 billion.
- The widest YoY moves for Dividends Paid - Common: up 9875.0% in 2023, down 0.93% in 2023.
- A 5-year view of Dividends Paid - Common shows it stood at $1.1 billion in 2022, then rose by 1.31% to $1.2 billion in 2023, then rose by 5.0% to $1.2 billion in 2024, then climbed by 3.61% to $1.3 billion in 2025, then grew by 1.66% to $1.3 billion in 2026.
- According to Business Quant data, Dividends Paid - Common over the past three periods registered $1.3 billion, $1.3 billion, and $1.3 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 1.55 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 3.13 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 3.09 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -3.29 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 2.11 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 1.36 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 1.04 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 2.45 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Bristol Myers Squibb | 244.56 Mn | -10.21 Bn | 8.07 Bn | 1.28 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.28 Bn |
| Mar 31, 2026 | 1.28 Bn |
| Dec 31, 2025 | 1.26 Bn |
| Dec 31, 2025 | 1.26 Bn |
| Sep 30, 2025 | 1.26 Bn |
| Sep 30, 2025 | 1.26 Bn |
| Jun 30, 2025 | 1.26 Bn |
| Jun 30, 2025 | 1.26 Bn |
| Mar 31, 2025 | 1.26 Bn |
| Mar 31, 2025 | 1.26 Bn |
| Dec 31, 2024 | 1.22 Bn |
| Dec 31, 2024 | 1.22 Bn |
| Sep 30, 2024 | 1.22 Bn |
| Sep 30, 2024 | 1.22 Bn |
| Jun 30, 2024 | 1.22 Bn |
| Jun 30, 2024 | 1.22 Bn |
| Mar 31, 2024 | 1.21 Bn |
| Mar 31, 2024 | 1.21 Bn |
| Dec 31, 2023 | 1.16 Bn |
| Dec 31, 2023 | 1.16 Bn |